GSK has struck a voluntary agreement with the US government to lower the cost of prescription medicines and expand access to ...

The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

GSK committed $270 million up front in recent months to gain access to early-stage assets in the class of cancer therapies known as antibody drug conjugates, or ADCs. The deals are part of a broad ...

GSK has outperformed both the healthcare sector and S&P 500 this year, which is notable considering the spectre of high ...

The European Medicines Agency has recommended the approval of GSK's add-on drug to treat asthma and a chronic inflammatory sinus condition, the company said on Friday.

GSK is sticking to its plan to gradually monetize its stake in Haleon, the consumer health business the British pharma giant spun off in 2022. GSK has collected about 978 million pounds ($1.24 billion ...

Editor’s note: LimeLight is a regular feature from WRAL TechWire offering another means of publishing noteworthy news. Be sure to check out more LimeLight worthy news at this link. RESEARCH TRIANGLE ...

Havas Health and Creative Networks hired Harriet Flory as global chief communications officer, reporting to global CEO Donna ...

Propeller Health, a company that trains its digital eye on respiratory medicine, first partnered with GSK in 2015. Now, that collaboration is being expanded -- enabling both companies to prepare for, ...

We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other healthcare stocks under ...

The comprehensive solar panel project is designed to generate electricity equivalent to more than 70% of the Oak Hill site’s annual usage and reduce its carbon footprint by 60% As the designated ...